References |
1 |
Metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine after oral administration to rats and dogs
|
2 |
Biotransformation of two citrus flavanones by lactic acid bacteria in chemical defined medium
|
3 |
Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate
|
4 |
Ipratropium bromide: drug metabolism and pharmacokinetics
|
5 |
Ligand-induced conformational change in penicillin acylase
|
6 |
A breakthrough in enzyme technology to fight penicillin resistance-industrial application of penicillin amidase
|
7 |
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review J Psychiatry Neurosci. 1992 Nov;17(5):206-14.
|
8 |
DrugBank(Pharmacology-Metabolism):Sodium phenylbutyrate
|
9 |
In vitro catabolism of 3',4'-dihydroxycinnamic acid by human colonic microbiota
|